Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News BioDelivery Sciences International Inc. BDSI

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.


Recent & Breaking News (NDAQ:BDSI)

BioDelivery Sciences Announces Agreement with CVS/Caremark for BELBUCA® and BUNAVAIL® Through 2020

PR Newswire June 21, 2017

Biotech Stock Performance Review -- Cellect Biotechnology, BioDelivery Sciences, BioLine Rx, and Benitec Biopharma

PR Newswire June 6, 2017

BioDelivery Sciences to Present at the Jefferies 2017 Healthcare Conference and the William Blair 2017 Growth Stock Conference

PR Newswire June 1, 2017

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  May 26, 2017

15 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  May 17, 2017

BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update

PR Newswire May 15, 2017

Investor Network: BioDelivery Sciences International, Inc. to Host Earnings Call

Accesswire May 15, 2017

Earnings Scheduled For May 15, 2017

Benzinga.com  May 15, 2017

BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2017 Financial Results on Monday, May 15

PR Newswire May 9, 2017

18 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  May 2, 2017

BioDelivery Sciences Announces the Approval of BUNAVAIL® for Induction of Buprenorphine Treatment for Opioid Dependence

PR Newswire May 2, 2017

BioDelivery Sciences to Present at the Deutsche Bank 42nd Annual Health Care Conference

PR Newswire April 26, 2017

Research Reports Coverage on Biotech Stocks -- Novan, Stemline Therapeutics, BioDelivery Sciences, and OncoGenex Pharma

PR Newswire April 25, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  March 31, 2017

18 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  March 31, 2017

BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book Further Extending and Strengthening Patent Protection on BELBUCA®, BUNAVAIL® and ONSOLIS®

PR Newswire March 31, 2017

Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

PR Newswire March 24, 2017

BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results

PR Newswire March 17, 2017

BioDelivery Sciences Announces Three Data Presentations on BELBUCA® at the American Academy of Pain Medicine 33rd Annual Meeting

PR Newswire March 16, 2017

BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2016 Financial Results on Friday, March 17

PR Newswire March 9, 2017